A tale of two companies with a similar market cap: which to buy?
On one hand, we have an AIDS drug in Phase III trials with a global market. Lots of cash on hand.
On the other, a complementary medicine waiting for marketing approval to a virtually-bankrupt Russian health system. Virtually no cash, and are having difficulty in raising.
It's a no-brainer, really.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.010(5.26%) |
Mkt cap ! $10.66M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.0¢ | $9.06K | 49.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31000 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 7422 | 1 |
View Market Depth
| Last trade - 14.41pm 19/09/2025 (20 minute delay) ? |
| SLA (ASX) Chart |